
March 21, 2024
RegMed Investors (RMi) Closing Bell: The cell and gene therapy sector faltered
March 21, 2024
RegMed Investors’ (RMi) pre-open: Not for nothing
March 20, 2024
RegMed Investors’ (RMi) pre-open: caution
March 19, 2024
RegMed Investors (RMi) Closing Bell: Short-volatility based trades or actual sentiment shaping?
March 19, 2024
RegMed Investors’ (RMi) pre-open: riding the wave
March 18, 2024
RegMed Investors (RMi) Closing Bell: a session of cell and gene therapy sector shifting share pricing
March 18, 2024
RegMedInvestors (RMi) Research Note – finance: bluebird bio (BLUE)Secures up to $175 M Debt Financing with Hercules Capital
March 18, 2024
RegMed Investors’ (RMi) pre-open: which way to safety?
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors